Chemomab Therapeutics Ltd. Increase (Decrease) in Receivables
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Receivables of -$2.31 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2020-03-17
- Chemomab Therapeutics Ltd. increase (decrease) in receivables for fiscal 2019 was -$2.31M, a 165.93% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. increase (decrease) in receivables for fiscal 2018 was $3.50M.
| Period end | Increase (Decrease) in Receivables 12 month |
|---|---|
| 2019-12-31 | -$2.31M 10-K · filed 2020-03-17 |
| 2018-12-31 | $3.50M 10-K · filed 2020-03-17 |